Lumicks

Lumicks Cancer Immunotherapy Development - EIB Financing

Borrower(s)
Lumicks
Industry
Social projects/Healthcare
Area of finance
Development Bank Finance
Region
Europe
Europe
Countries
Netherlands

Project Overview

EIB and LUMICKS have signed a €20 million ($22 million) venture debt agreement to accelerate the launch of its next generation, high throughput cell avidity platform. The financing is supported by the European Commission under the InvestEU initiative. Amsterdam-based LUMICKS’ next...

show more
Deal Volume
$22.23m
Dealmakers

Did you work on this project?

This deal page needs more information from those involved.

Tag yourself TAG A COLLEAGUE SUGGEST AN EDIT

Tranches

To view all tranche and pricing information, login or upgrade to a subscription here